KDM1B and neoplasm: Although the precise mechanisms underlying this transfer remain to be determined, we speculate that once transferred from dying to viable cells, nucleic acids act as DAMPs leading to IFN-I production, which ultimately drives KDM1B-mediated cancer cell reprogramming, and, thus, therapy failure and tumor regrowth.